尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Amello Jason. Officer active across 1 company, notably Candel Therapeutics, Inc.. Cumulatively, 4 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €5k. Activity tracked since 28 November 2022. The latest transaction was filed on 28 November 2023 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Amello Jason is a declarant associated with Candel Therapeutics, Inc., where he is Chief Financial Officer. The record shows 4 filings in total, and across the 4 sampled recent filings, the period runs from 2022-11-30 to 2023-11-30, with EUR 4983 in buys and EUR 0 in sells, and the most common transaction nature is Attribution.